X4 Pharmaceuticals Inc —— 资产负债表 (NASDAQ:XFOR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 122.87 M117.18 M155.59 M147.26 M146.45 M290.46 M 负债总额 50.07 M52.76 M81.53 M96.16 M124.3 M104.17 M 权益总额 72.8 M64.41 M74.05 M51.1 M22.15 M186.29 M 负债及股东权益总额 122.87 M117.18 M155.59 M147.26 M146.45 M290.46 M 总债务 37.77 M33.93 M33.62 M54.57 M77.66 M75.99 M 净债务 -40.94 M-47.85 M-88.1 M-59.63 M-24.44 M-177.01 M

新闻

Stifel重申X4 Pharmaceuticals股票评级,临床试验进展顺利

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

X4 Pharmaceuticals在Leerink全球医疗保健会议上宣布战略转向罕见血液病领域

X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology

Guggenheim initiates X4 Pharmaceuticals stock with buy rating

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

欧洲药品管理局专家组支持mavorixafor用于超罕见WHIM综合征治疗

EMA panel backs mavorixafor for ultra-rare WHIM syndrome

Vericel Corporation (VCEL) Matches Q4 Earnings Estimates

X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy